RESUMO
The aim of the present study was to determine whether the transient receptor potential vanilloid (TRPV1) receptor protein as well as the calcitonin gene-related peptide (CGRP) content could be enhanced after the i.p. administration of 5 mg/kg lipopolysaccharide (LPS) to Sprague-Dawley rats. In tongue tissue, used as a representative model of TRPV1 receptors expression, there was a significant increase in the abundance of TRPV1 receptor protein 6 h after LPS administration. In mesenteric arteries, the density of the CGRP-positive nerves as well as the release of CGRP induced by 10 microM anandamide was also significantly increased 6 h after LPS administration. The relaxant responses induced by anandamide in mesenteric beds isolated from either untreated or LPS-treated rats were abolished after a 2 h exposure to 10 microM capsaicin. Moreover, anandamide-induced relaxations of untreated mesenteries were potentiated by the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA, 0.1 microM), but not by its inactive analogue 4alpha-phorbol (0.1 microM). The potentiation of anandamide effects caused by the PKC activator was accompanied by a significant increase in the overflow of CGRP induced by anandamide in the untreated rats. It is proposed that the overexpression of the TRPV1 receptors and the increased content of CGRP could contribute to the enhancement of anandamide effects during the endotoxemic shock. An eventual phosphorylation event linked to the overflow of CGRP could also participate in the enhanced relaxation caused by anandamide in endotoxemia.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/biossíntese , Endotoxemia/metabolismo , Canais de Cátion TRPV/biossíntese , Animais , Ácidos Araquidônicos/farmacologia , Endocanabinoides , Endotoxemia/etiologia , Lipopolissacarídeos , Masculino , Mesentério/efeitos dos fármacos , Mesentério/fisiologia , Norepinefrina/farmacologia , Forbóis/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Proteína Quinase C/metabolismo , Ratos , Ratos Sprague-Dawley , Acetato de Tetradecanoilforbol/farmacologia , Língua/metabolismo , Vasoconstritores/farmacologia , Vasodilatação/efeitos dos fármacosRESUMO
The in vitro exposure to anandamide elicits greater relaxations in mesenteric beds isolated from female compared to male rats. The present work shows that in mesenteric beds precontracted with noradrenaline the removal of endothelium increased the relaxation caused by anandamide in male and ovariectomized female but not in sham-operated female rats. The nitric oxide synthase inhibition with 100 microM N(omega)-nitro-L-arginine methyl ester hydrochloride (L-NAME) and the sensory in vivo denervation through neonatal administration of capsaicin also reduced anandamide-induced relaxations but these effects had the same extent in male and in female mesenteries. The content of calcitonin gene related peptide (CGRP) in mesenteric beds, that was higher in intact female than in male rats, was reduced by ovariectomy and restored to control values 21 days after a 3 weekly i.m. administration of 450 microg/kg 17beta-oestradiol. This latter treatment also increased CGRP content in mesenteries from males up to the same levels observed in females. The basal release of CGRP in mesenteric beds was equivalent in either sex, but the exposure to anandamide increased CGRP release solely in female mesenteries. The ratio prostacyclin/thromboxane A(2) was selectively reduced in mesenteries from male rats after exposure to anandamide, due to the decrease of the tissue levels of prostacyclin. Moreover, the cyclooxygenase-2 inhibitor 0.1 microM N-[2-(cyclohexyloxy)-4-nitrophenyl]-methanesulphonamide (NS-398) diminished the relaxations caused by anandamide solely in female rats. It is proposed that relaxing factors such as CGRP and prostacyclin contribute to the higher relaxations caused by anandamide in the vasculature of female rats.
Assuntos
Ácidos Araquidônicos/farmacologia , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Moduladores de Receptores de Canabinoides/farmacologia , Endotélio Vascular/efeitos dos fármacos , Epoprostenol/metabolismo , Alcamidas Poli-Insaturadas/farmacologia , Animais , Endocanabinoides , Endotélio Vascular/fisiologia , Estradiol/farmacologia , Feminino , Técnicas In Vitro , Masculino , Artérias Mesentéricas/efeitos dos fármacos , Artérias Mesentéricas/fisiologia , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Ovariectomia , Ratos , Ratos Sprague-Dawley , Fatores Sexuais , Tromboxano A2/metabolismo , Vasodilatação/efeitos dos fármacosRESUMO
In urethane-anesthetized rats the intrathecal (i.t.) injection of 100 nmol anandamide produced a hypotensive effect (-19.3+/-1.6 mm Hg; n=6) that was mimicked by i.t. administration of 0.25 nmol calcitonin gene-related peptide (CGRP; -26.2+/-1.8 mm Hg, n=4). Both effects were antagonized either by the CGRP receptor antagonist CGRP(8-37) (5 nmol; i.t.) or by the gamma-aminobutyric acid (GABA)(A) receptor antagonist bicuculline (8.8 nmol, i.t) or by the GABA(B) receptor antagonist 2-hydroxy saclofen (110 nmol; i.t.). On the contrary, blockade of spinal CGRP receptors by CGRP(8-37) did not modify the hypotensive response to either the GABA(A)-receptor agonist muscimol (8.8 nmol; i.t.) or the GABA(B)-receptor agonist baclofen (100 nmol; i.t). This result suggests a unidirectional effect of CGRP on the GABAergic system. The response to anandamide remained unaltered after acute inhibition of nitric oxide (NO) synthase activity by either i.t. (1 micromol) or i.v. (10 mg/kg) injection of N(G)-nitro-L-arginine methyl ester (L-NAME), but increased significantly after long-term L-NAME administration (70 mg/kg/day; four weeks; p.o.), thus suggesting compensatory changes in cardiovascular homeostasis. It is proposed that the hypotensive effect of anandamide in urethane-anesthetized rats could involve the release of CGRP followed by the release of GABA in the spinal cord. NO does not appear to have a direct participation in the spinal mechanisms involved in the decrease of the blood pressure caused by anandamide.
Assuntos
Ácidos Araquidônicos/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Peptídeo Relacionado com Gene de Calcitonina/fisiologia , Ácido gama-Aminobutírico/fisiologia , Animais , Anti-Hipertensivos/farmacologia , Ácidos Araquidônicos/administração & dosagem , Baclofeno/administração & dosagem , Baclofeno/farmacologia , Benzoxazinas , Bicuculina/administração & dosagem , Bicuculina/farmacologia , Peptídeo Relacionado com Gene de Calcitonina/administração & dosagem , Peptídeo Relacionado com Gene de Calcitonina/farmacologia , Antagonistas do Receptor do Peptídeo Relacionado ao Gene de Calcitonina , Bloqueadores dos Canais de Cálcio/administração & dosagem , Bloqueadores dos Canais de Cálcio/farmacologia , Moduladores de Receptores de Canabinoides/farmacologia , Capsaicina/administração & dosagem , Capsaicina/farmacologia , Relação Dose-Resposta a Droga , Endocanabinoides , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/farmacologia , Agonistas GABAérgicos/administração & dosagem , Agonistas GABAérgicos/farmacologia , Antagonistas GABAérgicos/administração & dosagem , Antagonistas GABAérgicos/farmacologia , Injeções Intravenosas , Injeções Espinhais , Masculino , Morfolinas/administração & dosagem , Morfolinas/farmacologia , NG-Nitroarginina Metil Éster/administração & dosagem , NG-Nitroarginina Metil Éster/farmacologia , Naftalenos/administração & dosagem , Naftalenos/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Fragmentos de Peptídeos/administração & dosagem , Fragmentos de Peptídeos/farmacologia , Alcamidas Poli-Insaturadas , Ratos , Ratos Sprague-Dawley , Receptores de Peptídeo Relacionado com o Gene de Calcitonina/agonistas , Receptores de Peptídeo Relacionado com o Gene de Calcitonina/fisiologia , Fatores de TempoRESUMO
Although cannabinoids have been recreationally employed for thousands of years, it was not until the discovery of their specific receptors, in the early nineties, that the molecular basis of cannabinoid activity have began to be understood. Growing research in this field has demonstrated not only that the action of cannabinoids in mammals is mainly receptor-mediated, but also that endogenous cannabinoids, such as anandamide, are produced, metabolized, and taken up across the cell membrane through a facilitated uptake process. The exogenous administration of cannabinoids, as well as the manipulation of their endogenous levels have been related to a variety of effects, such as analgesia, impairment of cognition and learning, appetite enhancement and peripheral vasodilation. Hence, the endocannabinoid system, including the CB1 and CB2 receptors, the metabolizing enzyme fatty acid amide hydrolase and the anandamide transporter, is a potential target for the development of novel therapeutic drugs in the treatment of various conditions, such as pain, feeding disorders and vascular disease among others. Although most of the research in the field of cannabinoids has been focused on their effects in the central nervous system, a growing line of evidence indicates that cannabinoids can also play a major role in the control of physiopathological functions in the cardiovascular system. In this context, endocannabinoids have been proposed as novel possible hypotensive agents, and have been involved in the hypotension observed in septic shock, acute myocardial infarction and cirrhosis. In addition, a protective role for endocannabinoids has been described in ischemia.
Assuntos
Moduladores de Receptores de Canabinoides/fisiologia , Canabinoides/farmacologia , Doenças Cardiovasculares/metabolismo , Receptores de Canabinoides/metabolismo , Animais , Moduladores de Receptores de Canabinoides/metabolismo , Canabinoides/uso terapêutico , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/fisiopatologia , Modelos Animais de Doenças , Desenho de Fármacos , HumanosRESUMO
Anandamide (0.01 to 10 microM) caused greater concentration-dependent reductions of the contractile-induced responses to noradrenaline in female than in male mesenteric vascular beds isolated from adult Sprague-Dawley rats. Greater relaxant responses in females were also induced by the vanilloid TRPV1 receptor agonist capsaicin (0.01 to 10 microM), whereas no sex differences were observed for the relaxations caused by either acetylcholine or sodium nitroprusside. The effect of anandamide in either sex was reduced by the vanilloid TRPV1 receptor antagonist capsazepine but not by the cannabinoid CB1 receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR141716A). In males, the anandamide-induced relaxations were potentiated by in vitro exposure during 5 min to 0.5 microM 17beta-oestradiol and unmodified by the protein synthesis inhibitor cycloheximide. The vasorelaxant effects of anandamide in female rats were decreased by ovariectomy. This decrease was prevented by in vivo treatment with 17beta-oestradiol-3-benzoate (450 microg/kg i.m., once a week during 3 weeks) and counteracted by in vitro exposure to oestrogen. In vivo treatment with 17beta-oestradiol also potentiated anandamide-induced responses in males. In conclusion, this study shows an oestrogen-dependent sensitivity to the vanilloid TRPV1 receptor-mediated vasorelaxant effects of anandamide in the mesenteric vasculature of Sprague-Dawley rats, that could be mediated by both genomic and non-genomic mechanisms.
Assuntos
Ácidos Araquidônicos/farmacologia , Capsaicina/análogos & derivados , Estradiol/análogos & derivados , Estrogênios/fisiologia , Mesentério/efeitos dos fármacos , Caracteres Sexuais , Vasodilatação/efeitos dos fármacos , Acetilcolina/farmacologia , Animais , Ácidos Araquidônicos/antagonistas & inibidores , Argentina , Capsaicina/farmacologia , Chile , Cicloeximida/farmacologia , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Endocanabinoides , Estradiol/sangue , Estradiol/imunologia , Estradiol/farmacologia , Estrogênios/sangue , Estrogênios/farmacologia , Feminino , Masculino , Mesentério/irrigação sanguínea , Mesentério/patologia , Músculo Liso Vascular/efeitos dos fármacos , Nitroprussiato/farmacologia , Norepinefrina/antagonistas & inibidores , Norepinefrina/farmacologia , Ovariectomia , Fluoreto de Fenilmetilsulfonil/farmacologia , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas , Pirazóis/farmacologia , Ratos , Ratos Sprague-Dawley , Rimonabanto , Fatores de Tempo , Vasodilatação/fisiologiaRESUMO
This study examined the effect of intrathecal (i.t.) injection of the endocannabinoid anandamide in urethane-anesthetized rats. The tip of the i.t. cannula was positioned at the T(12)-L(1) level of the spinal cord. Either anandamide or its metabolically stable analogue methanandamide (25 to 100 nmol) produced dose-dependent decreases in the blood pressure that persisted at least for up to 30 min. The hypotensive responses to 100 nmol anandamide and to 100 nmol methanandamide were -17.7+/-1.6 mmHg ( n=5) and -17.9+/-2.0 mmHg ( n=4), respectively. Hypotensive effects were also obtained with the CB(1) cannabinoid receptor agonist WIN 55212-2 (20 nmol; i.t.) as well as with the vanilloid VR(1) receptor agonist capsaicin (3 nmol; i.t.). Nicotinic ganglionic blockade with hexamethonium bromide [10 mg/kg; intravenous(i.v.)] abolished the responses to both anandamide and capsaicin. The i.t. administration of the CB(1) receptor antagonist, 20 nmol SR 141716A, as well as the VR(1) receptor antagonist, 20 nmol capsazepine, prevented almost completely the hypotensive responses to both anandamide and methanandamide. SR 141716A prevented the hypotension caused by WIN 55212-2 but did not modify the response to the vanilloid receptor agonist capsaicin. On the contrary, capsazepine antagonized the hypotension caused by capsaicin but failed to affect the decrease in blood pressure caused by the CB1 cannabinoid receptor agonist WIN 55212-2. These results suggest that anandamide could modulate the blood pressure through the activation of cannabinoid CB(1) receptors and vanilloid VR(1) receptors localized at the spinal cord.
Assuntos
Anestésicos Intravenosos/farmacologia , Anti-Hipertensivos/farmacologia , Ácidos Araquidônicos/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Capsaicina/análogos & derivados , Receptor CB1 de Canabinoide/efeitos dos fármacos , Receptores de Droga/efeitos dos fármacos , Medula Espinal/efeitos dos fármacos , Uretana/farmacologia , Anestesia Intravenosa , Animais , Benzoxazinas , Pressão Sanguínea/efeitos dos fármacos , Capsaicina/farmacologia , Relação Dose-Resposta a Droga , Endocanabinoides , Bloqueadores Ganglionares/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Hexametônio/farmacologia , Injeções Espinhais , Masculino , Morfolinas/farmacologia , Naftalenos/farmacologia , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas , Pirazóis/farmacologia , Ratos , Ratos Sprague-Dawley , RimonabantoRESUMO
In rat isolated mesenteric beds that were contracted with NA as an in vitro model of the vascular adrenergic hyperactivity that usually precedes the onset of primary hypertension, the oral administration (3 daily doses) of either 10 mg/kg genistein or 20 mg/kg daidzein potentiated the anandamide-induced reduction of contractility to NA in female but not in male rats. Oral treatment with phytoestrogens also restored the vascular effects of anandamide as well as the mesenteric content of calcitonin gene-related peptide (CGRP) that were reduced after ovariectomy. The enhancement of anandamide effects caused by phytoestrogens was prevented by the concomitant administration of the estrogen receptor antagonist fulvestrant (2.5 mg/kg, s.c., 3 daily doses). It is concluded that, in the vasculature of female rats, phytoestrogens produced an estrogen-receptor-dependent enhancement of the anandamide-vascular actions that involves the modulation of CGRP levels and appears to be relevant whenever an adrenergic hyperactivity occurs.
RESUMO
The intrathecal (i.t.) injection of 50 and 100 nmol anandamide to urethane anesthetized rats induced a dose-dependent decrease in the mean blood pressure (-10.6+/-1.6 mmHg and -15.0+/-1.7 mmHg, respectively; n=6) whereas a lower dose of this endocannabinoid (25 nmol) was devoid of effect. Similar responses were obtained both with the non-metabolizable analog methanandamide and with the endocannabinoid N-arachidonoyldopamine. When the sub-effective dose (25 nmol) of each compound was co-injected with palmitoylethanolamide (100 nmol), significant decreases in the blood pressure were observed (-12.3+1.3 mmHg for anandamide; -12.1+/-0.8 mmHg for methanandamide; -12.1+/-0.8 mmHg for N-arachidonoyldopamine; n=4-6). Palmitoylethanolamide also enhanced the hypotensive responses to the 50 nmol-dose of both anandamide and methanandamide. The hypotensive response induced by co-administration of palmitoylethanolamide and 25 nmol anandamide was prevented both by the cannabinoid CB(1) receptor antagonist SR 144716A (20 nmol; i.t.) and by the vanilloid TRPV1 receptor antagonist capsazepine (20 nmol; i.t.) and enhanced by pretreatment with URB602 (3.5 nmol; i.t.), a putative inhibitor of palmitoylethanolamide degradation. These results suggest that in the spinal cord palmitoylethanolamide acts as an entourage compound for the hypotensive effects of i.t. administered endocannabinoids. The facilitative action of palmitoylethanolamide affects the vanilloid TRPV1 as well as the cannabinoid CB(1) receptor-mediated effects of endocannabinoids on the blood pressure control.
Assuntos
Anti-Hipertensivos/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Moduladores de Receptores de Canabinoides/farmacologia , Endocanabinoides , Ácidos Palmíticos/farmacologia , Amidas , Animais , Compostos de Bifenilo/farmacologia , Antagonistas de Receptores de Canabinoides , Moduladores de Receptores de Canabinoides/administração & dosagem , Capsaicina/análogos & derivados , Capsaicina/farmacologia , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Etanolaminas , Frequência Cardíaca/efeitos dos fármacos , Injeções Espinhais , Masculino , Ácidos Palmíticos/antagonistas & inibidores , Ratos , Ratos Sprague-Dawley , Canais de Cátion TRPV/antagonistas & inibidoresRESUMO
In the isolated rat mesenteric bed, the 1 min perfusion with 100 nm anandamide, a concentration that did not evoke vasorelaxation, elicited an acute release of 165.1 +/- 9.2 pmol nitric oxide (NO) that was paralleled by a 2-fold increase in cGMP tissue levels. The rise in NO released was mimicked by either (R)-(+)-methanandamide or the vanilloid receptor agonists resiniferatoxin and (E)-capsaicin but not by its inactive cis-isomer (Z)-capsaicin. The NO release elicited by either anandamide or capsaicin was reduced by the TRPV1 receptor antagonists 5'-iodoresiniferatoxin, SB 366791 and capsazepine as well as by the cannabinoid CB(1) receptor antagonists SR 141716A or AM251. The outflow of NO elicited by anandamide and capsaicin was also reduced by endothelium removal or NO synthase inhibition, suggesting the specific participation of endothelial TRPV1 receptors, rather than the novel endothelial TRPV4 receptors. Consistently, RT-PCR showed the expression of the mRNA coding for the rat TRPV1 receptor in the endothelial cell layer, in addition to its expression in sensory nerves. The participation of sensory nerves on the release of NO was precluded on the basis that neonatal denervation of the myenteric plexus sensory nerves did not modify the pattern of NO release induced by anandamide and capsaicin. We propose that low concentrations of anandamide, devoid of vasorelaxing effects, elicit an acute release of NO mediated predominantly by the activation of endothelial TRPV1 receptors whose physiological significance remains elusive.
Assuntos
Ácidos Araquidônicos/farmacologia , Endotélio Vascular/efeitos dos fármacos , Artéria Mesentérica Superior/efeitos dos fármacos , Canais de Cátion TRPV/efeitos dos fármacos , Anilidas/farmacologia , Animais , Antagonistas de Receptores de Canabinoides , Capsaicina/análogos & derivados , Capsaicina/farmacologia , Cinamatos/farmacologia , GMP Cíclico/metabolismo , Diterpenos/farmacologia , Relação Dose-Resposta a Droga , Endocanabinoides , Endotélio Vascular/metabolismo , Técnicas In Vitro , Masculino , Artéria Mesentérica Superior/metabolismo , Óxido Nítrico/metabolismo , Nitroarginina/farmacologia , Perfusão , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas , Pirazóis/farmacologia , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Rimonabanto , Canais de Cátion TRPV/genética , Canais de Cátion TRPV/metabolismo , Vasodilatação/efeitos dos fármacosRESUMO
The aim of the present experiments was to study the effects of exogenously added anandamide on transient norepinephrine (NE)-induced contractions in mesenteric beds isolated from adult male Sprague-Dawley rats 6 h after the i.p. administration of 5 mg kg(-1) lipopolysaccharide (LPS). LPS treatment induced a 3-fold increase in total nitric-oxide synthase (NOS) activity without modifying either the systolic blood pressure or the vascular reactivity to NE of the isolated mesenteric bed. The endocannabinoid anandamide (0.01-10 microM) caused concentration-dependent reductions of the contractile responses to NE in the isolated mesenteric bed. This effect was significantly potentiated after LPS treatment compared with the controls. Anandamide-induced reductions of the contractile responses to NE in mesenteric beds isolated from LPS-treated rats were unmodified by endothelium removal but significantly diminished by either the anandamide amidase inhibitor phenylmethylsulfonyl fluoride (200 microM) or the vanilloid receptor antagonist capsazepine (1 microM). The vanilloid receptor agonist capsaicin (0.01-100 nM) also caused concentration-dependent relaxations that were potentiated in mesenteric beds from LPS-treated rats. Nevertheless, they were unmodified by 1 microM capsazepine. It is concluded that the potentiation of anandamide relaxations after LPS treatment, which are evident at early stages of endotoxic shock, could involve the participation of an anandamide metabolite and might be mediated, at least in part, through a vanilloid receptor.
Assuntos
Ácidos Araquidônicos/farmacologia , Endotoxemia/fisiopatologia , Norepinefrina/antagonistas & inibidores , Circulação Esplâncnica/efeitos dos fármacos , Vasoconstritores/antagonistas & inibidores , Amidoidrolases/antagonistas & inibidores , Animais , Ácidos Araquidônicos/antagonistas & inibidores , Pressão Sanguínea/efeitos dos fármacos , Moduladores de Receptores de Canabinoides , Capsaicina/farmacologia , Endocanabinoides , Inibidores Enzimáticos/farmacologia , Lipopolissacarídeos/farmacologia , Masculino , Relaxamento Muscular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo III , Norepinefrina/farmacologia , Fluoreto de Fenilmetilsulfonil/farmacologia , Alcamidas Poli-Insaturadas , Ratos , Ratos Sprague-Dawley , Receptores de Droga/antagonistas & inibidores , Choque Séptico/tratamento farmacológico , Choque Séptico/fisiopatologia , Vasoconstritores/farmacologiaRESUMO
En el presente trabajo se estudió la capacidad del lecho mesentérico de rata para producir y liberar prostanoides en presencia y en ausencia del endotelio vascular, así como los efectos de los agentes vasodilatadores acetilcolina y bradiquinina sobre esta producción. La liberación de prostanoides se midió por cromatografía líquida de alta presión (HPLC). Se concluye que el lecho mesentérico de rata produce prostanoides vasodilatadores y vasoconstrictores de origen endotelial y extraendotelial. Por otro lado la acetilcolina y la bradiquinina estimulan la liberación de prostanoides de manera diferente y a través de mecanismos distintos. El efecto de la bradiquinina especialmente en ausencia del endotelio se podría traducir en un mayor predominio de prostaglandinas vasodilatadoras
Assuntos
Animais , Masculino , Ratos , Acetilcolina , Bradicinina , Endotélio , Óxido Nítrico/biossíntese , Prostaglandinas , Ratos Wistar , VasodilatadoresRESUMO
En el presente trabajo se estudió la capacidad del lecho mesentérico de rata para producir y liberar prostanoides en presencia y en ausencia del endotelio vascular, así como los efectos de los agentes vasodilatadores acetilcolina y bradiquinina sobre esta producción. La liberación de prostanoides se midió por cromatografía líquida de alta presión (HPLC). Se concluye que el lecho mesentérico de rata produce prostanoides vasodilatadores y vasoconstrictores de origen endotelial y extraendotelial. Por otro lado la acetilcolina y la bradiquinina estimulan la liberación de prostanoides de manera diferente y a través de mecanismos distintos. El efecto de la bradiquinina especialmente en ausencia del endotelio se podría traducir en un mayor predominio de prostaglandinas vasodilatadoras (AU)